Acta Chim. Sinica ›› 2019, Vol. 77 ›› Issue (5): 406-417.DOI: 10.6023/A18120504 Previous Articles     Next Articles



张晓蕾a,b, 田甘c, 张潇b, 王清a, 谷战军b   

  1. a 山东科技大学 土木工程与建筑学院 青岛 266590;
    b 中国科学院高能物理研究所 中国科学院纳米生物效应与安全性重点实验室 北京 100049;
    c 第三军医大学第一附属医院病理学研究所&西南癌症中心 肿瘤免疫病理学教育部重点实验室 重庆 400038
  • 投稿日期:2018-12-17 发布日期:2019-02-14
  • 通讯作者: 张潇, 王清;
  • 作者简介:张晓蕾,2016年本科毕业于山东科技大学土木工程与建筑学院;同年进入山东科技大学,攻读硕士学位;2017年7月,进入中国科学院高能物理研究所纳米生物效应与安全性重点实验室联合培养.主要研究的方向是纳米材料的合成及生物医学应用;田甘,副教授,博士.2015年毕业于四川大学化学学院,获得博士学位.研究生期间以“协同创新培养计划”联培于中科院纳米生物效应与安全性重点实验室,主要研究方向为荧光上转换纳米材料的可控合成及其生物医学研究.目前从事无机纳米材料的可控合成及其生物效应研究.主要研究方向为气体信使小分子的可控输运及其在肿瘤治疗中的应用;王清,博士生导师,主要从事固体力学,复合材料力学以及纳米压印技术方面的研究;谷战军,博士生导师,国家优秀青年基金获得者.主要从事新型纳米材料的可控合成及其生物效应研究.
  • 基金资助:


Controlled Release of Carbon Monoxide Based on Nanomaterials and Their Biomedical Applications

Zhang Xiaoleia,b, Tian Ganc, Zhang Xiab, Wang Qinga, Gu Zhanjunb   

  1. a College of Civil Engineering and Architecture, Shandong University of Science and Technology, Qingdao 266590;
    b CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049;
    c Institute of Pathology and Southwest Cancer Center, First Affiliated Hospital, Third Military Medical University, and Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing 400038
  • Received:2018-12-17 Published:2019-02-14
  • Contact: 10.6023/A18120504;
  • Supported by:

    Project supported by the National Basic Research Programs of China (Nos. 2016YFA0201600, 2016YFA0202104), the National Natural Science Foundation of China (Nos. 51822207, 51772292, 31571015, 11621505, 11435002, 81703071) and Youth Innovation Promotion Association of Chinese Academy of Sciences (No. 2013007) and Chongqing Basic and Frontier Research Program (No. cstc2016jcyjA0279) and Military Medical Science and Technology Innovation Program of Southwest Hospital (Nos. SWH2016LHJC-07, SWH2016JCYB-01 and SWH2017YQPY-03).

In recent years, the use of gas therapy has been more and more concerned by researchers in biomedical applications. Carbon monoxide (CO) is a diatomic gas messenger molecule with the function of transmitting intercellular information and regulating cellular signals. CO is found to play an extremely important physiological role in multiple systems, including cardiovascular system, nervous system, immune system, endocrine system and respiratory system, cancer therapy, coagulation and fibrinolysis system, organ transplantation and preservation, and so on. The biological functions of carbon monoxide molecule greatly depend on the its concentration, position, and duration. However, the existing carbon monoxide donors including Mn2(CO)10, Ru2Cl4(CO)6, Ru(CO)3Cl(glycinato), CORM-F, CORM-A1 have some disadvantages, such as poor stability, difficulties in dose control, lack of targeting, potential toxic and side effects on normal cells and tissues, which limited their further applications. How to control the concentration of carbon monoxide in the specific region has always been a big challenge in the field of biomedical applications. With the rapid development of nanoscience and technology, researchers have constructed a series of multifunctional carbon monoxide releasing nanomaterials, provided a new idea for CO controlled release, and applied them in the field of biomedicine. In this paper, several kinds of endogenous/exogenous stimulus-responsive CO releasing nanomaterials with the unique advantages are introduced based on the stimuli source. Then, the applications of these controlled CO releasing nanomaterials in biomedical fields, such as inhibiting inflammation, anti-bacte- rial and cancer therapy, are summarized. Finally, the challenges and prospects of CO releasing nanomaterials are discussed.

Key words: carbon monoxide, nanomaterials, controlled release, endogenous/exogenous stimulation, carbon monoxide nanodrugs